Legemiddelbransjen bruker 19 ganger mer på markedsføring enn utvikling

[AnonymBruker]

http://www.huffingtonpost.com/2012/08/09/pharmaceutical-companies-marketing_n_1760380.html

 

Big Pharma might be working a lot harder to sell you products than to develop new ones.

Prescription drug companies aren't putting a lot of resources toward new, groundbreaking medication, according to a recent report in BMJ, a medical journal based in London. Instead, it's more profitable for them to simply to create a bunch of products that are only slightly different from drugs already on the market, the reports authors said.

The authors go on to say that for every dollar pharmaceutical companies spend on "basic research," $19 goes toward promotion and marketing.

And apparently it's been working. Drug company revenues climbed more than $200 billion in the years between 1995 and 2010, according to the website MinnPost. Meanwhile, in recent years, more than one in five Americans age 50 and up have had to cut down on their dosages or switch to cheaper generic drugs because the cost of medication is so high.

http://www.huffingtonpost.com/2012/08/09/pharmaceutical-companies-marketing_n_1760380.html

 

Tankevekkende. De tjener også penger som gress.

 

As Drug Prices Continue To Soar, Big Pharma Reaped $84 Billion In Profits Last Year

 

The price of brand-name drugs has skyrocketed over the past several years, leading increasing numbers of Americans to switch over to cheaper generic drugs. But even those generic drugs are also increasingly costing Americans more money, as chain pharmacies across the country hike their prices to charge up to 18 times the drugs’ original cost. There’s one clear winner in this equation: the giant pharmaceutical companies that are raking in the profits.

 

http://thinkprogress.org/health/2013/04/08/1835991/big-pharma-billion-profits/

Anonymous poster hash: f5c94...8e0

[Gjest Gargamel]

Det var en veldig tankevekkende artikkel. Jeg har alltid hørt argumentet om at medisiner må være dyre fordi det er veldig dyrt å utvikle dem. Det er bare tull om man skal tro denne artikkelen.

Jeg får litt lyst til å se tallene bak tallene. Forholdet 1/19 på FOU/marked antyder at farmasøytisk industri bruker mye mindre på utvikling enn annen industri, og det høres litt rart ut.